(Q73046900)

English

A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia

scientific article published on 01 November 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9023787%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9023787%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

O Benkert

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9023787%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

G Gründer

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9023787%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

H Wetzel

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9023787%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

D Hackett

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9023787%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 November 1996

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9023787%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Journal of Psychiatric Research

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9023787%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

30

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9023787%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

441-451

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9023787%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9023787%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900029-5

7 January 2021

A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900029-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900029-5

7 January 2021

Subchronic antidepressant treatment with venlafaxine or imipramine and effects on blood pressure and heart rate: assessment by automatic 24-hour monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900029-5

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900029-5

7 January 2021

Comparison between zimeldine and amitriptyline of efficacy and adverse symptoms--a combined analysis of four British clinical trials in depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900029-5

7 January 2021

Progress in psychiatry (2).

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900029-5

7 January 2021

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900029-5

7 January 2021

The pharmacologic treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900029-5

7 January 2021

One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900029-5

7 January 2021

Time course of improvement under antidepressant treatment: a survival-analytical approach

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900029-5

7 January 2021

Sertraline 50 mg daily: the optimal dose in the treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900029-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0022-3956(96)00029-5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9023787%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9023787%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73046900&oldid=1944818101"